CA9 and cancer: These results correspond to previous findings that knockdown of CAIX or interference with the CAIX PG domain by an antibody, but not inhibition of CA catalytic activity, decreases cell proliferation in hypoxic MCF-7 and MDA-MB-231 cancer cells (Jamali et al., 2015; Ames et al., 2018).